The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Greenhouse gas emissions of Roche, Sanofi, and AstraZeneca in 2024, by scope (in metric tons of COâ‚‚ equivalent)
GHG emissions of Roche, Sanofi, and AstraZeneca in 2024, by scope
In 2024, AstraZeneca reported the highest total greenhouse gas emissions among the three pharmaceutical companies, with nearly *** million metric tons of CO₂e from Scope 3, compared to **** million at Roche and **** million at Sanofi. Scope 1 and Scope 2 emissions were comparatively small for all three companies, with Sanofi reporting the highest Scope 1 emissions among the three companies in 2024 at nearly *** thousand CO₂e.
Log in or register to access precise data.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Greenhouse gas emission intensity of Novartis, Sanofi a AstraZeneca in 2024, by scope
- Premium Statistic Global pharmaceutical greenhouse gas footprint changes by effect and region 1995-2019
- Premium Statistic Benefits among biopharma sustainability leaders and late adopters 2024
- Premium Statistic Benefits due to sustainability initiatives among biopharma companies 2024
- Premium Statistic Slowdowns due to poor sustainability progress among biopharma companies 2024
- Premium Statistic Statements on sustainability issues among biopharma companies 2024
- Premium Statistic Technologies important for biopharma sustainability targets 2024
- Basic Statistic Proactive patients in reviewing select health information and issues 2013
- Basic Statistic Satisfaction or desire for received pharmaceutical services in the U.S. 2013
- Basic Statistic Top five services from pharma companies for U.S. patients 2013
About the region
10
- Premium Statistic Global GHG footprint growth in pharma and health industry 1995-2019
- Premium Statistic Global biotechnology market share by region 2012
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
- Premium Statistic Employee distribution of Bracco in 2023, by role and gender
- Premium Statistic Employee distribution at Bracco in 2023, by geographic area
- Premium Statistic Employees joining Bracco in 2023, by age
- Premium Statistic Employee number at Bracco in 2023, by type of contract
- Premium Statistic Revenue of leading hundred pharmaceutical products by region 2012
- Premium Statistic Merck & Co. - costs of marketing and administration 2009-2017
- Premium Statistic Revenue of the pharmaceutical company Bracco 2020, by geographical area
Selected statistics
10
- Premium Statistic GHG reduction targets of leading pharma companies by 2030 and 2045, by scope
- Premium Statistic Novo Nordisk net profit 2009-2025
- Basic Statistic Number of pharmaceutical preparation enterprises in Norway 2016-2023
- Basic Statistic Number of clinical trial starts in Denmark 2018-2023
- Premium Statistic Clinical trials in Denmark by therapeutic area 2018-2023
- Basic Statistic Number of applications for clinical trials in Norway 2008-2024
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
- Basic Statistic Sales value of nonprescription pharmaceuticals in Norway 2017-2021
- Premium Statistic Personnel costs of the pharmaceutical industry in Italy 2023, by region
- Basic Statistic Import value of pharmaceuticals into Sweden 2012-2024
Other regions
10
- Basic Statistic Forecast major categories of U.S. healthcare expenditures 2015-2020
- Basic Statistic Expected consequences of moving US pharma manufacturing to the US, by gender
- Basic Statistic Americans on US pharma quality compared to foreign pharma 2017, by gender
- Basic Statistic Number of pharmaceutical preparations enterprises in Slovakia 2021-2024
- Basic Statistic Number of pharmaceutical preparations enterprises in Slovenia 2021-2024
- Basic Statistic Number of pharmaceutical preparations enterprises in Romania 2021-2024
- Basic Statistic Number of pharmaceutical preparations enterprises in Portugal 2021-2024
- Basic Statistic Number of pharmaceutical preparations enterprises in Poland 2021-2024
- Basic Statistic Number of pharmaceutical preparations enterprises in the Netherlands 2021-2024
- Basic Statistic Number of pharmaceutical preparations enterprises in Latvia 2021-2024
Related statistics
10
- Premium Statistic Italy: perception of pharmaceutical companies 2018, by brand
- Premium Statistic Operating profit Celltrion 2017-2024
- Premium Statistic Sales revenue Sanofi S.r.l. in Italy 2020-2022
- Premium Statistic Sales revenue Novartis Farma S.p.A in Italy 2020-2022
- Premium Statistic Sales revenue Eli Lilly Italia S.p.A. in Italy 2020-2022
- Premium Statistic Sales revenue AbbVie S.r.l. in Italy 2020-2022
- Premium Statistic Sales revenue Yuhan 2023, by sector
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Advertising and promotion expenses of Yunnan Baiyao Group 2017-2022
- Premium Statistic Operating income Yuhan 2015-2023
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Various sources (druganddeviceworld.com). (April 21, 2025). Greenhouse gas emissions of Roche, Sanofi, and AstraZeneca in 2024, by scope (in metric tons of COâ‚‚ equivalent) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 31, 2026, from /statistics/1624054/ghg-emissions-of-roche-sanofi-and-astrazeneca-by-scope/
Various sources (druganddeviceworld.com). "Greenhouse gas emissions of Roche, Sanofi, and AstraZeneca in 2024, by scope (in metric tons of COâ‚‚ equivalent)." Chart. April 21, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 31, 2026. /statistics/1624054/ghg-emissions-of-roche-sanofi-and-astrazeneca-by-scope/
Various sources (druganddeviceworld.com). (2025). Greenhouse gas emissions of Roche, Sanofi, and AstraZeneca in 2024, by scope (in metric tons of COâ‚‚ equivalent). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 31, 2026. /statistics/1624054/ghg-emissions-of-roche-sanofi-and-astrazeneca-by-scope/
Various sources (druganddeviceworld.com). "Greenhouse Gas Emissions of Roche, Sanofi, and Astrazeneca in 2024, by Scope (in Metric Tons of Coâ‚‚ Equivalent)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 21 Apr 2025, /statistics/1624054/ghg-emissions-of-roche-sanofi-and-astrazeneca-by-scope/
Various sources (druganddeviceworld.com), Greenhouse gas emissions of Roche, Sanofi, and AstraZeneca in 2024, by scope (in metric tons of COâ‚‚ equivalent) ÌÇÐÄÆƽâ°æ, /statistics/1624054/ghg-emissions-of-roche-sanofi-and-astrazeneca-by-scope/ (last visited July 31, 2026)
Greenhouse gas emissions of Roche, Sanofi, and AstraZeneca in 2024, by scope (in metric tons of COâ‚‚ equivalent) [Graph], Various sources (druganddeviceworld.com), April 21, 2025. [Online]. Available: /statistics/1624054/ghg-emissions-of-roche-sanofi-and-astrazeneca-by-scope/
Advertisement